With two weeks to go, confusion surrounds hep C drug advice

A LACK of clarity surrounds prescribing guidelines for new-generation hepatitis C drugs that are set to be PBS authority-listed in two weeks.

The guidelines give all GPs the ability to prescribe the three new direct-acting antivirals (DAAs) “in consultation” with specialists and state patient eligibility criteria.

Sydney GP Dr David Baker, who has a special interest in hepatitis C, is concerned GPs, whether experienced or not, won’t know what information needs to be supplied to the PBS, liver clinics or specialist hepatologists, gastroenterologists and

Latest

Trending